← All indications
Insulin Resistance
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
Subtype terms (1)
More specific conditions that are subtypes of Insulin Resistance in the MeSH hierarchy.
- Metabolic Syndrome
395 drugs (148 approved, 247 experimental)
Drugs by status
Phase 4 trials (58)
- zidovudine
- calcium
- acetylsalicylic acid
- ledipasvir
- insulin human
- myoinositol
- interferon alpha-2b
- isosorbide
- glipizide
- eplerenone
- exenatide
- sitagliptin
- ribavirin
- glimepiride
- olanzapine
- losartan
- lactobacillus reuteri
- ertugliflozin
- metyrapone
- alogliptin
- bisoprolol
- ramipril
- voglibose
- nevirapine
- norgestimate
- aripiprazole
- acarbose
- ethinyl estradiol
- ziprasidone
- dydrogesterone
- +28 more
Phase 3 trials (33)
- salicylic acid
- sufonylurea
- vitamin c
- rosiglitazone
- icosapent ethyl
- dapagliflozin
- dlbs3233
- vildagliptin
- totum-63
- leptin
- tadalafil
- conjugated linoleic acid
- maltodextrin
- acacia
- glucose monohydrate
- hepatitis b immune globulin (human)
- propylformic acid
- hydroxychloroquine
- oligofructose
- sodium chloride
- soybean oil
- bromocriptine
- fish oil
- triticum aestivum pollen
- empagliflozin
- arginine
- levocarnitine
- amiloride
- resveratrol
- salsalate
- +3 more
Phase 2 trials (60)
- coconut oil
- bismuth
- taurine
- Lactobacillus acidophilus
- saxagliptin
- somatropin
- mifepristone
- azd9668
- tlc-3595
- pegvisomant
- letrozole
- canakinumab
- eritoran
- rifaximin
- colchicine
- human fecal microbiota
- alpha-lipoic acid
- Hesperedin
- diacerein
- sacubitril
- chromium
- elafibranor
- ginseng
- triflusal
- sildenafil
- ursolic acid
- acyline
- procaine benzylpenicillin
- omeprazole
- bsl_ep044
- +30 more
Phase 1 trials (57)
- bvs857
- tenofovir
- growth hormone
- incb13739
- calcitriol
- etravirine
- ta-65
- dulaglutide
- physostigmine
- bfkb8488a
- piperine
- phentolamine mesylate
- p-aminohippuric acid
- ritonavir
- thiamine
- ketoconazole
- carbon dioxide
- norepinephrine
- he3286
- galantamine
- last 5 amino acids of glp-1
- octreotide
- kq-791
- tilarginine
- angiotensin 1-7
- egg
- urea
- dexamethasone
- trimethaphan
- glucagon
- +27 more
Other trials (152)
- beta-hydroxyisovaleric acid
- human choriogonadotropin alfa
- propionibacterium freudenreichii
- insulin lispro
- bilberry
- flax
- chickpea
- l-glutamine
- escitalopram
- human milk
- sirolimus
- raspberry
- water
- pectin
- cocoa butter
- cranberry
- erythritol
- amino acids
- dehydroepiandrosterone
- lactic acid
- eubacterium hallii
- sunflower oil
- palmitoleic acid
- corticotropin
- spironolactone
- agave
- oleuropein
- olive
- kefir
- soybean
- +122 more
Organizations
Organization Involved with Phase 4 Indications (136)
- Escuela Superior de Medicina del IPN
- German Diabetes Center
- Srinakharinwirot University
- University of Yaounde
- University of Colorado
- Hospital General de México Dr. Eduardo Liceaga
- State University of New York, Brooklyn
- Osaka University
- Universidad de Guanajuato
- Indian Council of Medical Research
- Aristotle University of Thessaloniki
- Purdue University
- Tottori University
- Kos Pharmaceuticals
- National Institutes of Health (NIH)
- Government of Taiwan
- State University of New York, Buffalo
- SmithKline Beecham
- University of Dundee
- Leo Pharma
- AstraZeneca
- Government of Mexico
- Ghent University
- University of Kentucky
- Bristol-Myers Squibb
- University of Toronto
- Government of Singapore
- Abbott
- University of Basel
- Humboldt University
- +106 more
Organization Involved with Phase 3 Indications (78)
- University of Missouri
- Leiden University
- DSM
- St. Louis University
- Universidad de Colima
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Alberta
- Biofortis
- University of Pavia
- Guangzhou Medical University
- Washington University in St. Louis
- Catalysis SL
- Instituto Mexicano del Seguro Social
- clinique ovo
- Jaeb Center for Health Research
- Joslin Diabetes Center
- Rafik Hariri University
- Medical Center Leeuwarden
- Dexa Medica Group
- Baylor University
- Utrecht University
- UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France
- Government of Nova Scotia
- Airlangga University
- University of Western Australia
- University of Exeter
- Wayne State University
- The University of Hong Kong
- Kaohsiung Medical University
- The Campbell Foundation
- +48 more
Organization Involved with Phase 2 Indications (92)
- University of Bari
- Dicofarm
- National Institute of Allergy and Infectious Diseases (NIAID)
- Biosearch S.A.
- University of Nantes
- Northern Ontario School of Medicine
- University of Grenoble
- Rockefeller University
- Pfizer
- Radboud University
- HYKS-instituutti Oy
- Ocean Nutrition
- University of South Florida
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Canadian Institutes of Health Research (CIHR)
- Profil GmbH
- Iperboreal Pharma Srl
- Laboratorios Silanes S.A. de C.V.
- National Center for Complementary and Integrative Health (NCCIH)
- Vastra Gotaland Region
- AIDS Clinical Trials Group
- Hoosier Cancer Research Network
- University of Tuebingen
- Gemphire Therapeutics, Inc.
- University of Porto
- Norwegian Council on Cardiovascular diseases
- Institut National de la Santé Et de la Recherche Médicale, France
- Tobira Therapeutics, Inc.
- University of Southern California
- Vestre Viken Ringerike Sykehus
- +62 more
Organization Involved with Phase 1 Indications (27)
- Los Angeles Biomedical Research Institute
- University of Connecticut
- Oregon Health and Science University
- University of Toulouse
- Tibotec
- Technical University of Munich
- Columbia University
- MUC Research GmbH
- Boston University
- Northwell Health
- Indiana University
- Integrity Nutraceuticals, Inc.
- Gilead Sciences
- Incyte
- Elahi, Dariush, PhD
- Mead Johnson
- Harbor Therapeutics
- Eli Lilly
- United States Department of Agriculture
- St Stephens Aids Trust
- ICON
- Genentech
- Aarhus University
- Texas Tech University
- Kaneq Bioscience
- University of Utah
- Alkermes
Organization Involved with Other Experimental Indications (143)
- Egg Nutrition Center
- Federal University of Rio de Janeiro
- Mars, Inc.
- Government of Czech Republic
- Rottapharm
- KineMed
- Mitacs
- Top Institute Food and Nutrition
- University of Roehampton
- General Mills Inc.
- Pontificia Universidad Catolica de Chile
- Thomas Jefferson University
- Dutch Diabetes Research Foundation
- Universidad de Antioquia
- Liverpool John Moores University
- BioKier Inc.
- Arla Foods
- DIANA Food
- German Research Foundation
- University of Montpellier
- Chiangmai University
- Centre de Recherche en Nutrition Humaine Rhone-Alpe
- Izmir Katip Celebi University
- MGP Ingredients, Inc
- Nestle
- Central South University
- U.S. Highbush Blueberry Council
- University of Heidelberg
- Ocean Spray, Inc.
- K. Marcinkowski University of Medical Sciences
- +113 more